Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 26 04:00PM ET
0.3490
Dollar change
+0.0460
Percentage change
15.18
%
Index- P/E- EPS (ttm)-0.25 Insider Own19.42% Shs Outstand53.08M Perf Week16.33%
Market Cap22.24M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float51.36M Perf Month25.31%
Income-14.14M PEG- EPS next Q-0.04 Inst Own3.89% Short Float1.87% Perf Quarter9.40%
Sales1.22M P/S18.23 EPS this Y- Inst Trans-5.69% Short Ratio3.13 Perf Half Y12.58%
Book/sh0.14 P/B2.46 EPS next Y- ROA-90.30% Short Interest0.96M Perf Year-9.59%
Cash/sh0.02 P/C16.12 EPS next 5Y- ROE-103.36% 52W Range0.25 - 0.49 Perf YTD24.60%
Dividend Est.- P/FCF- EPS past 5Y-27.91% ROI-152.00% 52W High-28.16% Beta1.65
Dividend TTM- Quick Ratio0.83 Sales past 5Y21.72% Gross Margin6.09% 52W Low39.54% ATR (14)0.02
Dividend Ex-Date- Current Ratio1.85 EPS Y/Y TTM8.35% Oper. Margin-959.46% RSI (14)69.59 Volatility11.45% 7.33%
Employees61 Debt/Eq0.04 Sales Y/Y TTM40.09% Profit Margin-1163.24% Recom1.00 Target Price3.00
Option/ShortYes / Yes LT Debt/Eq0.03 EPS Q/Q-106.84% Payout- Rel Volume3.54 Prev Close0.30
Sales Surprise-50.00% EPS Surprise-125.00% Sales Q/Q-38.55% EarningsFeb 17 AMC Avg Volume306.95K Price0.35
SMA2020.44% SMA5021.83% SMA2008.85% Trades Volume1,087,037 Change15.18%
Feb-23-24 12:01PM
Feb-16-24 07:05PM
Feb-01-24 09:20AM
Jan-23-24 09:20AM
Jan-17-24 09:20AM
09:20AM Loading…
Dec-19-23 09:20AM
Dec-13-23 09:30AM
Dec-06-23 08:30AM
Nov-21-23 08:30AM
Nov-13-23 08:00AM
Oct-19-23 03:30PM
Aug-21-23 02:30PM
Aug-14-23 08:30AM
Aug-02-23 08:30AM
Jul-18-23 05:22AM
08:44AM Loading…
Jul-12-23 08:44AM
Jul-07-23 09:15AM
Jul-06-23 07:46AM
Jun-06-23 09:20AM
Jun-05-23 08:30AM
May-18-23 08:30AM
Apr-24-23 09:00AM
Apr-18-23 08:30AM
Mar-22-23 08:30AM
Mar-20-23 08:45AM
Feb-14-23 07:41PM
Feb-08-23 08:30AM
Jan-04-23 08:00AM
Dec-20-22 08:30AM
Dec-07-22 08:30AM
08:30AM Loading…
Dec-01-22 08:30AM
Nov-30-22 11:19AM
Nov-01-22 04:30PM
Sep-21-22 06:00AM
Sep-12-22 07:00AM
Aug-08-22 06:00AM
Jun-22-22 11:26PM
Jun-21-22 12:15AM
Jun-08-22 09:03PM
Apr-18-22 05:28PM
Mar-23-22 04:55PM
Feb-10-22 04:30PM
Jan-19-22 09:29AM
Dec-14-21 09:25AM
Dec-08-21 05:43PM
Dec-02-21 09:32AM
Oct-29-21 10:09PM
Oct-15-21 04:00PM
Sep-07-21 07:30PM
Aug-11-21 08:00PM
Jul-22-21 07:00AM
Jun-23-21 06:50PM
Jun-14-21 06:00PM
Jun-07-21 11:26PM
May-14-21 06:01AM
Mar-08-21 06:33PM
Feb-22-21 08:00AM
Feb-12-21 07:00PM
Jan-13-21 06:19PM
Jan-11-21 02:13PM
Dec-22-20 08:00AM
Dec-05-20 07:05PM
Nov-23-20 09:00AM
Nov-22-20 08:48PM
Nov-14-20 09:18AM
Aug-20-20 02:45PM
Aug-13-20 07:36AM
Aug-12-20 09:40AM
Aug-11-20 05:03PM
Jul-21-20 07:00AM
Jul-20-20 07:00AM
Jul-13-20 04:45PM
May-07-20 10:00PM
Mar-26-20 08:30PM
Feb-10-20 05:30PM
Nov-06-19 09:32AM
07:00AM
Oct-04-19 07:00AM
Sep-19-19 07:00AM
Aug-09-19 07:00AM
Jul-26-19 05:25PM
Jun-26-19 02:12PM
Jun-25-19 10:53AM
09:27AM
Jun-17-19 07:00AM
Jun-14-19 01:06PM
Jun-13-19 05:32PM
Jun-12-19 05:40PM
Jun-07-19 03:01PM
Apr-22-19 07:00AM
Mar-26-19 09:00PM
Mar-12-19 10:00AM
Mar-04-19 12:00PM
Feb-21-19 07:52PM
Jan-02-19 10:00AM
Jan-01-19 12:01PM
Dec-31-18 01:36PM
09:28AM
Dec-30-18 10:14AM
Dec-28-18 01:00PM
IGC Pharma, Inc. engages in the development and commercialization of cannabinoid based alternative therapies for indications, such as Alzheimer's disease, Parkinson's disease, and pain. The firm is involved in researching the application of cannabinoids, such as Tetrahydrocannabinol and Cannabidiol in combination with other compounds to address various ailments, including Alzheimer's disease. It operates through the Infrastructure Business and Life Sciences segments. The Infrastructure Business segment is involved in the rental of heavy construction equipment, execution of construction contracts, and purchase and resale of physical commodities used in infrastructure. The Life Sciences segment includes a biotech component, and a vertically integrated hemp-cannabinoid based healthcare and wellness business, which involves the production of plant and cannabinoid-based products, and therapies. The company was founded by Ram Mukunda on April 29, 2005 and is headquartered in Potomac, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Moran James PDirectorMar 31Option Exercise0.0083,3340133,334Jun 28 01:46 PM
PRINS RICHARD KDirectorMar 31Option Exercise0.00158,3340913,334Jun 27 08:20 PM
MUKUNDA RAMCEOMar 31Option Exercise0.0033,3340777,418Jun 27 06:10 PM
MUKUNDA RAMCEOMar 31Option Exercise0.00566,66703,574,761Jun 27 06:10 PM
GRIMALDI CLAUDIAVICE PRESIDENT, CCO & PF0Mar 31Option Exercise0.00141,6670700,488Jun 28 09:25 PM